Home
Site Map
About Roche
Contact Us
Help
Clinical. Credible. Convenient.
Not a Member?
Log In
Forgot Password?
Instant Access Code
Sign Up
»
E-mail:
Password:
Code:
Remember Me
Log In
»
Go
»
Main Menu
Rheumatoid Arthritis Home
News
Clinical Trials
Education
Publications
Other Resources
Nurses' Corner
More Therapeutic Areas
Select an Area
Hepatology
Influenza
Oncology
Osteoporosis
More Roche Product Info
Select a Product
Boniva
Kytril
Pegasys
Tamiflu
Xeloda
Other Roche Products
Meeting Calendar
Select a link below to view details.
March 2010
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Search RocheExchange
Please use TWO or more words to qualify your search.
Example: What is the mechanism of action of Actemra?
Search
»
Rheumatoid Arthritis Publications
Download Acrobat Reader »
tocilizumab Publications
RA Disease Information
Conference Posters
Publication Search
Display by:
Publication date
Author
Alphabetical by Publication Title
G. Jones, A. Sebba, J. Gu et al
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
Ann Rheum Dis 2010 69(): 88 - 96
J. S. Smolen, A. Beaulieu, A. Rubbert-Roth et al
Effect of interleukin-6-receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double–blind, placebo-controlled, randomized trial
The Lancet 2008 371(): 987 - 997
P Emery, E. Keystone, J. Kremer et al
IL 6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti tumour necrosis factor biologicals: results from a 24 week multicentre randomized placebo controlled trial
Ann Rheum Dis 2008 67(): 1516 - 1523
M.C Genovese, J.D. McKay, E.L. Nasonov. et al
Interleukin-6-Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs
Arthritis and Rheumatism 2008 58(10): 2968 - 2980
